INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mignon Loh, MD
University of California, San Francisco
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uab Comprehensive Cancer Center
Birmingham, Alabama, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- Children'S Hospital Colorado Center for Cancer and Blood Disorders
Aurora, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Aflac Cancer Center and Blood Disorders Service of Children'S Healthcare of Atlanta - Egleston Campus
Atlanta, Georgia, United States
- Children'S Memorial Hospital - Chicago
Chicago, Illinois, United States
- Riley'S Children Cancer Center at Riley Hospital for Children
Indianapolis, Indiana, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- Warren Grant Magnuson Clinical Center - Nci Clinical Trials Referral Office
Bethesda, Maryland, United States
- Dana-Farber/harvard Cancer Center at Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- C.S. Mott Children'S Hospital at University of Michigan Medical Center
Ann Arbor, Michigan, United States
- Masonic Cancer Center at University of Minnesota
Minneapolis, Minnesota, United States
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
St Louis, Missouri, United States
- Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
New York, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Knight Cancer Institute at Oregon Health and Science University
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Dallas, Texas, United States
- Baylor University Medical Center - Houston
Houston, Texas, United States
- Children'S Hospital and Regional Medical Center - Seattle
Seattle, Washington, United States
- Midwest Children'S Cancer Center at Children'S Hospital of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2010
- Primary completion
- 31 Oct 2014
- Completion
- —
- Last update posted
- 23 Oct 2014
- Registered enrollment
- 49
- Registry id
- NCT01164163
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.